Skip to main content
. 2021 Mar 5;11:607531. doi: 10.3389/fonc.2021.607531

Figure 1.

Figure 1

Impact of immune-related adverse events (irAEs) on progression-free survival (PFS). PFS, progression-free survival; CI, confidence interval; irAE, immune-related adverse events; P-values <0.05 were considered statistically significant.